A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
Clinical trial NCT00991172 · COMPLETED
Trial details
- NCT number
- NCT00991172
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-05-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.